Cargando…

NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development

Alternative pre-mRNA splicing is a critical step to generate multiple transcripts, thereby dramatically enlarging the proteomic diversity. Thus, a common feature of most alternative splicing factor knockout models is lethality. However, little is known about lineage-specific alternative splicing reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chang-Hyun, Park, Sang-Moo, Lee, Sun-jae, Kim, Young-Dae, Jang, Se-Hwan, Woo, Seon-Min, Kwon, Taeg-Kyu, Park, Zee-Yong, Chung, Ik-Joo, Kim, Hye-Ran, Jun, Chang-Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191771/
https://www.ncbi.nlm.nih.gov/pubmed/34037780
http://dx.doi.org/10.1093/nar/gkab389
Descripción
Sumario:Alternative pre-mRNA splicing is a critical step to generate multiple transcripts, thereby dramatically enlarging the proteomic diversity. Thus, a common feature of most alternative splicing factor knockout models is lethality. However, little is known about lineage-specific alternative splicing regulators in a physiological setting. Here, we report that NSrp70 is selectively expressed in developing thymocytes, highest at the double-positive (DP) stage. Global splicing and transcriptional profiling revealed that NSrp70 regulates the cell cycle and survival of thymocytes by controlling the alternative processing of various RNA splicing factors, including the oncogenic splicing factor SRSF1. A conditional-knockout of Nsrp1 (NSrp70-cKO) using CD4Cre developed severe defects in T cell maturation to single-positive thymocytes, due to insufficient T cell receptor (TCR) signaling and uncontrolled cell growth and death. Mice displayed severe peripheral lymphopenia and could not optimally control tumor growth. This study establishes a model to address the function of lymphoid-lineage-specific alternative splicing factor NSrp70 in a thymic T cell developmental pathway.